Business Wire

NV-VERACODE

Share
As Developers Struggle to Prioritize Security Debt, Veracode Announces Latest Innovations to Identify and Unify Critical Risk

Black Hat USA Conference (booth #2536) – Veracode, a global leader in application risk management, today announced platform innovations to help organizations uncover, prioritize, and reduce security debt across their growing attack surface. Universal Connector and Application Security Heatmap, the two newest capabilities from Longbow powered by Veracode, allow organizations to quickly connect findings from any source and see the applications that are contributing to the most risk. Together, the Universal Connector and the Application Security Heatmap provide clear, operational insight into assets and issues, allowing remediation actions to be prioritized by quantifiable risk.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240801020287/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Figure 1: State of Software Security 2024 Language Snapshot (Graphic: Business Wire)

“The combination of mounting security debt, an expanding attack surface made more vulnerable by generative AI, and an overwhelming volume of security alerts makes it challenging for organizations to know which application risks to prioritize,” said Chris Eng, Chief Research Officer at Veracode. “In fact, our State of Software Security research shows that many organizations are more focused on remediating low-severity flaws than critical flaws. Security leaders need technology that enables them to effectively uncover and manage application risk, and then reduce that risk by focusing on the issues that matter most across their entire attack surface.”

Prioritization of Security Debt: Critical vs Non-critical

In its State of Software Security 2024 Language Snapshot, Veracode revealed the varying prevalence of “critical” and “non-critical” security debt among applications written in different languages. Critical security debt is defined for this report as high-severity flaws that remain unfixed for longer than a year. If exploited, these flaws would put the integrity and availability of organizations at serious risk.

The research found that while most security debt exists in first-party code written by in-house developers, the most critical security debt resides in third-party code (e.g., open-source software imported into the codebase). For example, 80 percent of critical debt in Java apps, and 63 percent in JavaScript apps, is in third-party code. The report also found about 51 percent of critical flaws in Java apps turn into security debt, while only about 45 percent of low to medium flaws progress into security debt.

Eng said, “With the overflowing volume of security flaws, developers are not prioritizing those that present the most risk. While focusing on non-critical flaws may result in some quick fixes, developers should use their limited capacity to work on fixing critical flaws with the highest potential impact on security.”

Putting Visibility and Prioritization First: Universal Connector & Application Security Heatmap

Building on Veracode’s acquisition of Longbow Security in April this year, and the introduction of Longbow’s Repo Risk Visibility and Analysis capability in May, Universal Connector and Application Security Heatmap are designed with developers’ time in mind. The capabilities provide operational oversight to help developers and security teams quickly identify and prioritize the most important fixes for growing security debt across their applications.

Universal Connector allows organizations to quickly access disparate source data they otherwise couldn’t bring into the Longbow platform, meaning they don’t have to wait for a tool-specific connector. The Application Security Heatmap maps the application back to the owner and shows a 90-day risk trend, as well as enabling customization of the risk threshold to meet organizational policy. Application security teams and developers can analyze each application, view the distribution of risk, and implement recommendations for the Best Next Action™ to remediate that risk.

“As organizations seek to find and fix mounting critical security debt, the need for risk-focused visibility and prioritization is clear,” said Derek Maki, Vice President of Product Management at Veracode. “The new capabilities in the Longbow platform provide our customers with a deeper understanding of an organization’s riskiest applications, plus the unique ability to identify the top five most impactful solutions for improvement.”

Enhanced by the Longbow acquisition, Veracode closes the gap between development and security teams, delivering visibility from code repositories to cloud assets and runtime. Longbow also identifies infrastructure-as-code and misconfiguration risk for cloud assets originating from repositories.

The Longbow Universal Connector and Application Security Heatmap are available immediately. For more information, please visit the website or watch the interview with Brian Roche, Veracode Chief Executive Officer, and Derek Maki.

The full State of Software Security 2024 Language Snapshot is available on the Veracode website.

Visitors to the Black Hat USA Conference, August 3-8, 2024, can learn more about Veracode’s platform and these new features by visiting Veracode’s booth #2536 for a demo.

About the State of Software Security Report

The Veracode State of Software Security 2024 report analyzed data from large and small companies, commercial software suppliers, software outsourcers, and open-source projects. The research draws from more than a million (1,007,133) applications across all scan types, 1,553,022 dynamic analysis scans, and 11,429,365 static analysis scans. All those scans produced 96 million raw static findings, 4 million raw dynamic findings, and 12.2 million raw software composition analysis findings.

About Veracode

Veracode is a global leader in Application Risk Management for the AI era. Powered by trillions of lines of code scans and a proprietary AI-assisted remediation engine, the Veracode platform is trusted by organizations worldwide to build and maintain secure software from code creation to cloud deployment. Thousands of the world’s leading development and security teams use Veracode every second of every day to get accurate, actionable visibility of exploitable risk, achieve real-time vulnerability remediation, and reduce their security debt at scale. Veracode is a multi-award-winning company offering capabilities to secure the entire software development life cycle, including Veracode Fix, Static Analysis, Dynamic Analysis, Software Composition Analysis, Container Security, Application Security Posture Management, and Penetration Testing.

Learn more at www.veracode.com, on the Veracode blog, and on LinkedIn and X.

Copyright © 2024 Veracode, Inc. All rights reserved. Veracode is a registered trademark of Veracode, Inc. in the United States and may be registered in certain other jurisdictions. All other product names, brands or logos belong to their respective holders. All other trademarks cited herein are property of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240801020287/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union13.12.2024 07:00:00 CET | Press release

Atopic dermatitis is a common, chronic, and flaring inflammatory skin disease characterized by persistent itch and recurrent skin lesions, and affects approximately up to 40 million people in the European Union (EU)1-4 Prurigo nodularis is a serious skin disease characterized by chronic itch, skin nodules covering large body areas, and poor sleep quality, which is estimated to affect up to 111 people per 100,000 in the EU5-10 Nemolizumab is a first-in-class monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31.2 IL-31 is a neuroimmune cytokine that drives itch and is involved in inflammation and skin barrier dysfunction in both atopic dermatitis and prurigo nodularis11-13 This positive opinion from the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommending the granting of marketing authorization of nemolizumab in the European Union (EU) for the treatment of both atopic dermatitis and prurigo n

FPT and DENSO Sign MOU to Accelerate Software-Defined Vehicle Innovation13.12.2024 06:58:00 CET | Press release

Global IT corporation FPT and global automotive components manufacturer DENSO signed a Memorandum of Understanding (MOU) to collaborate on advancing software-defined vehicles (SDV). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212915049/en/ The signing ceremony took place at DENSO Corporation Aichi Headquarters with the participation of Dr Truong Gia Binh, Chairman of FPT Corporation, Mr Shinnosuke Hayashi, President & CEO of DENSO Corporation, and senior leaders of both companies. (Photo: Business Wire) Under this MOU, the two companies will develop software for next-generation SDVs, with a particular emphasis on mass-production projects for Advanced Driver Assistance Systems (ADAS). Both companies aim to build a high-speed, high-quality global development framework, with plans for expansion by the end of 2027. The partnership is backed by FPT’s two decades of experience in automotive, a global team of 5,000 automotive

Kao Corporation: Regarding Shareholder Statement13.12.2024 05:48:00 CET | Press release

Oasis Management Company Ltd. (hereinafter referred to as “Oasis Management”), an investment management firm and a shareholder of our company, released a statement regarding Director candidates to be proposed at our 119th Ordinary General Meeting of Shareholders. Kao's Board of Directors and management team strive to increase shareholder value from a long-term perspective based on our business strategy. For the purpose of enhancing our corporate value, we are committed to engaging directly and constructively with all our stakeholders and welcome new perspectives to address challenges. Kao is constantly evolving its selection process to ensure an optimal composition of the Board of Directors. This year, the Committee for Examination of Nominees for Directors and Audit & Supervisory Board Members spent more than six months discussing the matter before reaching a final decision, and the decision was made before Oasis Management proposed any director candidates. The timing of the announcem

BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor13.12.2024 01:30:00 CET | Press release

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced it has entered into a global licensing agreement with CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (“CSPC”) for SYH2039, a novel methionine adenosyltransferase 2A (MAT2A)-inhibitor being explored for solid tumors. SYH2039 targets solid tumors that have a mutation called MTAP deletion, which is estimated to be present in approximately 15 percent of all cancer types with the most common including glioblastoma, pancreatic cancer and non-small cell lung cancer. “With one of the most dynamic solid tumor portfolios in the industry, we are continually assessing opportunities that align with our strategic focus and address significant unmet needs for patients. This MAT2A inhibitor is a valuable addition to our solid tumor pipeline, and we’re eager to explore its potential, particularly in combination with our internally de

Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas12.12.2024 23:30:00 CET | Press release

Six Late-Stage Programs with Peak Revenue Potential of $10B - $20B1 Poised to Deliver Sustainable GrowthExpected Phase 3 Data Readouts in 2025 for Oveporexton (TAK-861), Zasocitinib (TAK-279) and Rusfertide (TAK-121)Regulatory Filings for Oveporexton (Narcolepsy Type 1), Zasocitinib (Psoriasis) and Rusfertide (Polycythemia Vera) on Track for Fiscal Years 2025 - 2026Five Additional Filings Anticipated in Fiscal Years 2027 - 2029 Including First Indication Submissions for Mezagitamab (TAK-079), Fazirsiran (TAK-999) and Elritercept (TAK-226) Takeda (TSE:4502/NYSE:TAK) willhost an investor R&D Day today beginning at 8:30 a.m. JST in Tokyo. The meeting will focus on programs in the company’s late-stage pipeline, the transformative value they could deliver to patients, and the market opportunities they represent. “We are focused on advancing our innovative pipeline and accelerating late-stage programs to deliver sustainable revenue growth to 2030 and beyond, building upon the strong momentum

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye